While Chemours Company has underperformed by -2.31%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CC fell by -7.72%, with highs and lows ranging from $39.05 to $15.10, whereas the simple moving average fell by -8.54% in the last 200 days.
On April 09, 2024, BMO Capital Markets Upgraded Chemours Company (NYSE: CC) to Outperform. A report published by UBS on March 05, 2024, Downgraded its rating to ‘Neutral’ for CC. BMO Capital Markets also Downgraded CC shares as ‘Underperform’, setting a target price of $19 on the company’s shares in a report dated February 29, 2024. RBC Capital Mkts December 01, 2023d the rating to Outperform on December 01, 2023, and set its price target from $28 to $40. BofA Securities June 22, 2023d its ‘Buy’ rating to ‘Neutral’ for CC, as published in its report on June 22, 2023. UBS’s report from January 24, 2023 suggests a price prediction of $43 for CC shares, giving the stock a ‘Buy’ rating. BofA Securities also rated the stock as ‘Buy’.
Analysis of Chemours Company (CC)
CC currently pays a dividend of $1.00 per share, which means investors will get a return regardless of the company’s performance over the next few months. Further, the quarter-over-quarter increase in sales is 1.72%, showing a positive trend in the upcoming months.
In order to gain a clear picture of Chemours Company’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -25.70% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.00, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 2.07M can be a very valuable indicator of volatility for CC stock. On a monthly basis, the volatility of the stock is set at 4.51%, whereas on a weekly basis, it is put at 3.96%, with a loss of -4.25% over the past seven days. Furthermore, long-term investors anticipate a median target price of $31.50, showing growth from the present price of $27.51, which can serve as yet another indication of whether CC is worth investing in or should be passed over.
How Do You Analyze Chemours Company Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.20%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 76.52% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
CC shares are owned by institutional investors to the tune of 76.52% at present.
